Authors:
Neslihan Arıcı Haydarpasa Research and Training Hospital, Microbiology Laboratory, T.C. University of Health Sciences, Istanbul, Turkey

Search for other papers by Neslihan Arıcı in
Current site
Google Scholar
PubMed
Close
https://orcid.org/0000-0003-4788-0044
,
Sebahat Aksaray Department of Medical Microbiology, Faculty of Medicine Hamidiye, T.C. University of Health Sciences, Istanbul, Turkey

Search for other papers by Sebahat Aksaray in
Current site
Google Scholar
PubMed
Close
, and
Handan Ankaralı Department of Bioistatistic, Faculty of Medicine, Medeniyet University, Istanbul, Turkey

Search for other papers by Handan Ankaralı in
Current site
Google Scholar
PubMed
Close
Restricted access

Abstract

Bartonella henselae is the causative agent of cat scratch disease (CSD). In this study, we aimed to investigate the clinical data of patients with suspicion of CSD and delineate current epidemiological features.

A total of 785 patients with suspected CSD were included in the study. B. henselae IgM antibody was determined by indirect fluorescent antibody (IFA) test using a commercial kit (Euroimmun, Germany). Sex, age, clinical pre-diagnosis and animal contact information of the patients were obtained from hospital electronic database records.

Seventy-eight (9.9%) of 785 samples were seropositive. Out of 78 patients, 46 with animal contact data were further analyzed. Of these patients, 56% were male, and 41% were under 18 years of age. Seropositivity was more commonly observed in fall and winter. The most common finding was lymphadenitis (63%). Thirty-five patients (76%) had a previous history of animal contact (cat/dog). Of the 46 seropositive patients, 78.3, 15.2, 4.4, and 2.1% had titers of 1:80, 1:160, 1:320, and 1:640, respectively.

Our study confirms that CSD is not rare in Turkey. Thus, it should always be considered in the differential diagnosis of patients presenting with lymphadenopathy in all age groups, particularly children. Questioning of cat exposure should never be neglected, especially in areas with intense population of stray cats, such as Istanbul.

  • 1.

    Anderson BE, Neuman MA. Bartonella spp. as emerging human pathogens. Clin Microbiol Rev 1997; 10: 20319.

  • 2.

    Sander A, Posselt M, Oberle K, Bredt W. Seroprevalence of antibodies to Bartonella henselae in patients with cat scratch disease and in healthy controls: evaluation and comparison of two commercial serological tests. Clin Diagn Lab Immunol 1998; 5: 486.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3.

    Chaudhry R, Kokkayil P, Ghosh A, Bahadur T, Kant K, Sagar T, et al.. Bartonella henselae infection in diverse clinical conditions in tertiary care hospital in north India. Indian J Med Res 2018; 147: 18994.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Murakami K, Tsukahara M, Tsuneoka H, Iino H, Ishida C, Tsujino K, et al.. Cat scratch disease: analysis of 130 seropositive cases. J Infect Chemother 2002; 8: 34952.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5.

    Zangwill KM, Hamilton DH, Perkins BA, Regnery RL, Plikaytis BD, Hadler JL, et al.. Cat Scratch Disease in Connecticut: epidemiology, risk factors, and evaluation of a new diagnostic test. N Engl J Med 1993; 329: 81.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Lamas C, Curi A, Bóia MN, Lemos ERS. Human bartonellosis: seroepidemiological and clinical features with an emphasis on data from Brazil – a review. Mem Inst Oswaldo Cruz 2008; 103: 22135.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    Tsuneoka H, Tsukahara M. Analysis of data in 30 patients with cat scratch disease without lymphadenopathy. J Infect Chemother 2006; 12: 2246.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8.

    Asano T, Ichiki K, Koizumi S, Kaizu K, Hatori T, Fujino O. High prevalence of antibodies against Bartonella henselae with cervical lymphadenopathy in children. Pediatr Int 2010; 52: 5335.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Aydin N, Bülbül R, Tellı M, Gültekın B. Seroprevalence of Bartonella henselae and Bartonella quintana in blood donors in Aydin province, Turkey. Mikrobiyoloji Bulteni 2014; 48: 47783.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10.

    Ulug M. Evaluation of cat scratch disease cases reported from Turkey between 1996 and 2013 and review of the literature. Cent Eur J Public Health 2015; 23: 1705.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11.

    Atıcı S, Kadayıfcı EK, Karaaslan A, Toper MH, Celikel CA, Soysal A, et al.. Atypical presentation of cat-scratch disease in an immunocompetent child with serological and pathological evidence. Case Rep Pediatr 2014: 397437.

    • Search Google Scholar
    • Export Citation
  • 12.

    Sahin O. Cat-scratch disease: unusual perivascular chorioretinal lesions. Med Hypothesis Discov Innov Ophthalmol 2014: 3(4).

  • 13.

    Ulug M, Aslan V, Arik D, Yilmaz N, Üstün M. Two cases of cat scratch disease: a rare zoonotic infectious disease. KLIMIK J 2014; 27: 7881.

  • 14.

    Ak R, Doganay F, Akoglu EU, Ozturk TC. A challenging differential diagnosis of optic neuropathy in ED: CSD. BMJ Case Rep 2015; bcr-2015-210252.

  • 15.

    Oray M, Önal S, Koç Akbay A, Tuğal Tutkun İ. Diverse clinical signs of ocular involvement in cat scratch disease. Turk J Ophthalmol 2017; 47: 917.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16.

    Türker K, Çelebi B, Andaç Ş, Bulut P, Yalçın Ş, Dolhan S. A neglected bacteria with a case: Bartonella henselae. Mikrobiyol Bul 2017; 51: 28692.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17.

    Celiker H, Kazokoglu H, Eraslan M, Cerman E, Karabas L. Bartonella henselae neuroretinitis in patients without cat scratch. Jpn J Infect Dis 2018; 71: 397401.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18.

    Tsukahara M. Cat scratch disease in Japan. J Infect Chemother 2002; 8: 32125.

  • 19.

    Sun J, Fu G, Lin J, Song X, Lu L, Liu Q. Seroprevalence of Bartonella in Eastern China and analysis of risk factors. BMC Infect Dis 2010; 10: 121.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20.

    Vilibic-Cavlek T, Karlovic-Martinkovic D, Ljubin-Sternak S, Tabain I, Persic Z, Mlinaric-Galinovic G. High prevalence of Bartonella henselae and Bartonella quintana antibodies in Croatian patients presenting with lymphadenopathy. Pol J Microbiol 2012; 61: 31517.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21.

    Brunetti E, Fabbi M, Ferraioli G, Prati P, Filice C, Sassera D, et al.. Cat-scratch disease in Northern Italy: atypical clinical manifestations in humans and prevalence of Bartonella infection in cats. Eur J Clin Microbiol Infect Dis 2013; 32: 5314.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 22.

    Celebi B. Bartonella henselae and its infections. Mikrobiyol Bul 2008; 42: 16375.

  • 23.

    Im JH, Kwon HY, Baek J, Durey A, Lee SM, Park YK, et al.. Serologic study of Bartonella henselae in patients with acute undifferentiated febrile illness in Korea. Vector Borne Zoonotic Dis 2018; 18: 2916.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 24.

    Chomel BB, Kasten RW. Bartonellosis, an increasingly recognized zoonosis. J Appl Microbiol 2010; 109: 74350.

  • 25.

    Diren Sığırcı B, Ilgaz A. Detection of the presence of Bartonella henselae in cats in Istanbul. J Fac Vet Med Istanbul Univ 2013; 39: 20917.

    • Search Google Scholar
    • Export Citation
  • 26.

    Fiecek B, Chmielewski T, Lewandowska G, Tylewska-Wierzbanowska S. Characteristics of Bartonella spp. infections in Poland in the years 2009–2012 identified in the laboratory of National institute of public Health-National Institute of Hygiene. Przegl Epidemiol 2013; 67: 63740.

    • Search Google Scholar
    • Export Citation
  • 27.

    Windsor J. Cat-scratch disease: epidemiology, etiology and treatment. Br J Biomed Sci 2001; 58: 10110.

  • 28.

    Cunningham ET, Koehler JE. Ocular bartonellosis. Am J Ophthalmol 2000; 130: 3409.

  • 29.

    Vermeulen MJ, Herremans M, Verbakel H, Bergmans AM, Roord JJ, van Dijken PJ, et al.. Serological testing for Bartonella henselae infections in the Netherlands: clinical evaluation of immunofluorescence assay and ELISA. Clin Microbiol Infect 2007; 13: 62734.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 30.

    Herremans M, Vermeulen MJ, Van de Kassteele J, Bakker J, Schellekens JF, Koopmans MP. The use of Bartonella henselae-specific age dependent IgG and IgM in diagnostic models to discriminate diseased from non-diseased in cat scratch disease serology. J Microbiol Methods 2007; 71: 10713.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Collapse
  • Expand

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • CABELLS Journalytics
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded

2023  
Web of Science  
Journal Impact Factor 1.3
Rank by Impact Factor Q4 (Immunology)
Journal Citation Indicator 0.31
Scopus  
CiteScore 2.3
CiteScore rank Q3 (Infectious Diseases)
SNIP 0.389
Scimago  
SJR index 0.308
SJR Q rank Q3

Acta Microbiologica et Immunologica Hungarica
Publication Model Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article (only for OA publications)
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2025 Online subsscription: 772 EUR / 848 USD
Print + online subscription: 860 EUR / 944 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Apr 2024 58 0 0
May 2024 18 0 0
Jun 2024 24 0 1
Jul 2024 15 0 0
Aug 2024 44 0 0
Sep 2024 31 0 0
Oct 2024 17 0 0